| 4 | Statement of changes in beneficial owner... | Haas Jason | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 06/10/2025 | |
| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 06/10/2025 | |
| 4 | Statement of changes in beneficial owner... | Haas Jason | Donnelley Financial Solutions /fa | 11/20/2024 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 11/20/2024 | |
| 144 | Filing for proposed sale of securities u... | Syros Pharmaceuticals, Inc. | E Trade Financial Corp Llc Et Middle Office / Fa /fa | 11/18/2024 | |
| 144 | Filing for proposed sale of securities u... | Syros Pharmaceuticals, Inc. | Morgan Stanley Smith Barney Llc Executive Services /fa | 11/18/2024 | |
| 144 | Filing for proposed sale of securities u... | Haas Jason | E Trade Financial Corp Llc Et Middle Office / Fa /fa | 11/18/2024 | |
| 144 | Filing for proposed sale of securities u... | Haas Jason | Morgan Stanley Smith Barney Llc Executive Services /fa | 11/18/2024 | |
| 4 | Statement of changes in beneficial owner... | Haas Jason | Donnelley Financial Solutions /fa | 11/04/2024 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 11/04/2024 | |
| Load More |
SEC Filing Data
